Finn Partners Appoints Gil Bashe as Managing Partner

movers-and-shakers-gil-basheFinn Partners, an agency that specializes in the full spectrum of communications services, appointed Gil Bashe as the Managing Partner of Finn Partners Health. Bashe brings more than 12 years of industry experience and expertise, most recently serving as Health Practice Director at Makovsky & Company. He was also named one of the nation’s “Leading Crisis Communicators” by PR News and was inducted into its “PR Hall of Fame” in 2014.

“Gil is among the health public relations sector’s most proven leaders,” said Peter Finn, Founding Partner, Finn Partners, in a statement. “Gil has been at the helm of ‘Most Admired Health PR Agencies’—an unprecedented three times. He brings award-winning expertise encompassing pharma brand-building, product reimbursement and corporate, executive and issues reputation management. Beyond sheer knowledge, he is a mentor with a stellar client retention track record.”

MediScripts Appoints VP of Marketing and New Product Development

movers-and-shakers-stephen-hoelperMediScripts, a leading supplier of pharmaceutical marketing products, recently announced Stephen M. Hoelper as Vice President of Marketing and New Product Development. “Stephen brings the strategic product development, commercialization, sales and marketing experience necessary to best serve our pharmaceutical and physician partners in the rapidly evolving healthcare market,” Erez Lapsker, MediScripts CEO, said in a statement.

With more than 10 years of product development and marketing experience, Hoelper will push MediScripts to develop innovative technology products for healthcare practitioners.


Aridis Pharmaceuticals Inc

The biopharmaceutical company dedicated to making infectious disease immunotherapies, appointed Craig Gibbs, PhD, MBA, to the Board of Directors. Dr. Gibbs was last an executive for Gilead Sciences and has 30 years experience in both research and business roles.

Caris Life Sciences

The biotech company focused on development and innovation of precision medicine, appointed David Spetzler, PhD, as its Chief Scientific Officer. Dr. Spetzler has been on tenure with Caris as SVP of R&D and will continue to lead development of the Carisome TOP platform, a blood-based profiling technology.


The medical device and tissue processing company that focuses on cardiac and vascular surgery announced that Pat Mackin, President and CEO, has also been appointed Chairman of the Board due to the retirement of Steven Anderson, the previous Executive Officer. Anderson led the company for 30 years and will immediately hand over his position to Mackin, who will continue to lead the company’s global growth.


Robert Finkel is the Founder of the recently formed company, FreshBlood.With more than 17 years experience in the healthcare industry, he previously served as head of Kane & Finkel Healthcare Communications. Finkel will now lead this new healthcare communications consultancy.

Giant Creative/Strategy

Jeffrey Nemy was recently appointed as Chief Financial Officer. Prior to Giant, he served as Chief Operating Officer for Eveo Communications Group, Inc. and McCann Erickson, and as CFO at Northern California Public Broadcasting.

Intouch Solutions

Rachael Breidenthal was promoted to the position of Senior Art Director. She joined the agency in a full-time role six years ago. In this new position, she will work closely with clients to produce a creative product meant to accurately represent and effectively promote each unique brand.


The global healthcare advertising agency appointed Nicole Hyland as the first Senior Vice President, Chief Marketing Officer. Hyland was previously the Senior Vice President, Director of Client Services and will now optimize their brands and marketing operations in all divisions. She helped establish Natrel’s global credentials, gaining enough recognition for global business to bring in over a third of the company’s total revenue.

Ogilvy CommonHealth Worldwide

The global agency offering marketing services ranging from behavioral insights to medical education announced that Diane Iler-Smith has been selected as an inaugural executive juror for the 2015 CLIO Healthcare Awards. Iler-Smith is the EVP, Chief Creative Officer at Ogilvy Healthworld in New York City. Previously from Biolumina, she will serve on the Digital, Digital Techniques and Social Media judging panel.

Olympus Corporation America

One of the leading producers of medical and research microscopes appointed Mark Miller as its new Vice President, Corporate Communications. Miller will lead a new group called Corporate & Medical Communications and be responsible for driving communications creativity and collaboration with partners in the Americas.


The inVentiv Health  advertising agency that prides itself on ultra-creative ideas has named Michael Austin and Louis Massaia as Creative Directors. The pair worked together most recently at The CementBloc. They have both won numerous awards for their stunning advertising strategies for consumer and healthcare brands, while working with industry leaders such as HAVAS and Grey Healthcare.

PAREXEL International

Sean Gallimore joined PAREXEL International as Corporate Vice President and Chief Marketing Officer, responsible for the overall Marketing Function. Gallimore brings more than 20 years of healthcare marketing experience in diagnostics, informatics, medical devices and therapeutics.  Previously, he held leadership roles at Johnson & Johnson, Bayer, Philips, Medtronic and Smith & Nephew.


The developer and producer of injectable drug products appointed a new Senior Vice President, Chief Medical Officer, Richard L. Beckman, MD. Dr. Beckman has 13 years of clinical experience and 20 years of executive experience with companies such as Ophthotech Pharmaceuticals and Alcon Laboratories. Dr. Beckman will also serve as General Manager of Unilife’s Ocular Delivery Systems business unit.



You May Also Like

Washington Wire: Working Overtime

When is a salesman not a salesman? That was the question facing the U.S. ...

Healthcare Highlights

RELAPSE VACCINATION The FDA granted investigational new drug approval to the Mayo Clinic for ...

University of Pennsylvania Cofounds BluePen Biomarkers for Improved Biomarker Discovery

The University of Pennsylvania is helping to advance personalized medicine through improved biomarker discovery. ...